<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Inpatient Antimicrobial Guide</title>
<style>
body { font-family: Arial, sans-serif; margin:0; padding:0; display:flex; }
#sidebar { width:240px; background:#f8f8f8; padding:10px; border-right:1px solid #ccc; height:100vh; overflow-y:auto; }
#sidebar h2 { margin-top:0; }
#sidebar ul { list-style:none; padding-left:0; }
#sidebar li { margin:5px 0; cursor:pointer; color:#007BFF; }
#content { flex:1; padding:20px; overflow-y:auto; }
.expandable { background:#e2e2e2; padding:10px; margin:5px 0; cursor:pointer; border-radius:4px; }
.hidden { display:none; }
table { width:100%; border-collapse:collapse; margin:10px 0; }
th, td { border:1px solid #ccc; padding:5px; text-align:left; }
th { background:#f0f0f0; }
</style>
<script>
function showContent(id){
    document.querySelectorAll('#content > div').forEach(s=>s.style.display='none');
    var section = document.getElementById(id);
    if(section) section.style.display='block';
}
function toggleVisibility(id){
    var e = document.getElementById(id);
    e.style.display = (e.style.display === 'block') ? 'none' : 'block';
}
</script>
</head>
<body>

<div id="sidebar">
<h2>Sections</h2>
<ul>
<li onclick="showContent('homepage')">Home</li>
<li onclick="showContent('bacteria')">Bacterial Infections</li>
<li onclick="showContent('fungi')">Fungal Infections</li>
<li onclick="showContent('viruses')">Viral Infections</li>
<li onclick="showContent('pathogen')">Pathogen-Based Guidance</li>
<li onclick="showContent('overview')">Pathogen Overview</li>
<li onclick="showContent('classes')">Antibiotic Classes / Escalation</li>
<li onclick="showContent('references')">References</li>
</ul>
</div>

<div id="content">

<!-- Homepage -->
<div id="homepage">
<div style="text-align:center; margin-top:50px;">
<img src="mutant-icon.png" alt="Mutant Icon" style="width:150px; height:150px; margin-bottom:20px;">
<h1>Inpatient Antimicrobial Guide</h1>
<p>Select a section from the sidebar to view empiric therapy, culture-directed therapy, Gram-stain/diagnostic guidance, pathogen-specific recommendations, and detailed pathogen information.</p>
</div>
</div>

<!-- Bacterial Infections -->
<div id="bacteria" style="display:none">
<h2>Bacterial Infections</h2>

<h3>Community-Acquired Pneumonia (CAP)</h3>
<table>
<tr><th>Severity</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Outpatient, no comorbidities</td><td>Amoxicillin</td><td>1 g PO TID</td><td>5 days</td><td>-</td></tr>
<tr><td>Outpatient, comorbidities</td><td>Amox/Clav OR Cephalosporin + Macrolide</td><td>875/125 mg PO BID</td><td>5–7 days</td><td>Check allergies and local resistance</td></tr>
<tr><td>Inpatient, non-ICU</td><td>Ceftriaxone + Azithromycin</td><td>1–2 g IV q24h + 500 mg IV/PO q24h</td><td>5–7 days</td><td>Respiratory FQ alternative</td></tr>
<tr><td>ICU</td><td>Ceftriaxone + Azithromycin ± Vancomycin</td><td>As above</td><td>7–10 days</td><td>Add Pseudomonas coverage if risk factors</td></tr>
</table>

<h3>Hospital-Acquired Pneumonia (HAP)</h3>
<table>
<tr><th>Risk / Severity</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>No MRSA / Pseudomonas risk</td><td>Piperacillin-Tazobactam</td><td>4.5 g IV q6–8h</td><td>7 days</td><td>-</td></tr>
<tr><td>MRSA risk</td><td>Add Vancomycin</td><td>15 mg/kg IV q12h</td><td>7–10 days</td><td>Adjust for renal; monitor trough</td></tr>
<tr><td>Pseudomonas risk</td><td>Anti-pseudomonal beta-lactam (Cefepime)</td><td>2 g IV q8h</td><td>7 days</td><td>Combination therapy optional if critically ill</td></tr>
</table>

<h3>Urinary Tract Infections (UTI)</h3>
<table>
<tr><th>Type</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Uncomplicated cystitis</td><td>Nitrofurantoin</td><td>100 mg PO BID</td><td>5 days</td><td>Not for CrCl &lt;30</td></tr>
<tr><td>Complicated / pyelonephritis</td><td>Ceftriaxone OR Ciprofloxacin</td><td>1 g IV q24h OR 400 mg IV q12h</td><td>7–10 days</td><td>Adjust renal</td></tr>
<tr><td>Catheter-associated</td><td>Remove catheter + empiric therapy</td><td>Per culture</td><td>7–14 days</td><td>-</td></tr>
</table>

<h3>Skin & Soft Tissue Infections</h3>
<table>
<tr><th>Type</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Cellulitis (non-purulent)</td><td>Cephalexin</td><td>500 mg PO QID</td><td>5–7 days</td><td>MRSA uncommon</td></tr>
<tr><td>Purulent / abscess</td><td>Drainage ± Doxycycline</td><td>100 mg PO BID</td><td>5–10 days</td><td>MRSA coverage indicated</td></tr>
<tr><td>Necrotizing fasciitis</td><td>Vancomycin + Piperacillin-Tazobactam</td><td>IV per protocol</td><td>14–21 days</td><td>Immediate surgical intervention required</td></tr>
</table>

<h3>Intra-Abdominal Infections</h3>
<table>
<tr><th>Type</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Community-acquired, mild-moderate</td><td>Ceftriaxone + Metronidazole</td><td>1–2 g IV q24h + 500 mg IV q8h</td><td>4–7 days</td><td>Source control essential</td></tr>
<tr><td>Community-acquired, severe / ICU</td><td>Imipenem</td><td>1 g IV q8h</td><td>4–7 days</td><td>Adjust renal</td></tr>
<tr><td>Healthcare-associated / complicated</td><td>Meropenem</td><td>1 g IV q8h</td><td>7–10 days</td><td>Culture-directed therapy preferred</td></tr>
</table>

<h3>CNS Infections</h3>
<table>
<tr><th>Type</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Bacterial Meningitis</td><td>Ceftriaxone + Vancomycin ± Ampicillin</td><td>2 g IV q12h + 15 mg/kg IV q12h</td><td>7–21 days</td><td>Add Ampicillin if Listeria risk</td></tr>
<tr><td>Brain Abscess</td><td>Ceftriaxone + Metronidazole ± Vancomycin</td><td>Per protocol</td><td>6–8 weeks</td><td>Adjust per culture; surgical drainage recommended</td></tr>
</table>

<h3>Endocarditis</h3>
<table>
<tr><th>Pathogen / Type</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Streptococcus viridans, native valve</td><td>Penicillin G ± Gentamicin</td><td>Pen: 12–24 million units/day IV; Gent: 3 mg/kg/day IV</td><td>4 weeks (Pen), 2 weeks (Pen + Gent)</td><td>Adjust renal</td></tr>
<tr><td>Staphylococcus aureus, native valve</td><td>Nafcillin (MSSA) or Vancomycin (MRSA)</td><td>Nafcillin: 2 g IV q4h; Vancomycin: 15 mg/kg IV q12h</td><td>6 weeks</td><td>Monitor renal; check trough</td></tr>
<tr><td>Enterococcus spp.</td><td>Ampicillin + Gentamicin</td><td>Ampicillin: 2 g IV q4h; Gentamicin: 3 mg/kg/day IV</td><td>4–6 weeks</td><td>Adjust renal</td></tr>
</table>
</div>

<!-- Fungal Infections -->
<div id="fungi" style="display:none">
<h2>Fungal Infections</h2>

<h3>Candida spp.</h3>
<table>
<tr><th>Species</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>C. albicans</td><td>Micafungin</td><td>100 mg IV q24h</td><td>14 days after negative culture</td><td>Remove central lines</td></tr>
<tr><td>C. glabrata</td><td>Micafungin</td><td>100 mg IV q24h</td><td>14 days</td><td>Fluconazole-resistant common</td></tr>
<tr><td>C. parapsilosis</td><td>Fluconazole</td><td>400 mg IV/PO daily</td><td>14 days</td><td>-</td></tr>
</table>

<h3>Aspergillus spp.</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Voriconazole</td><td>6 mg/kg IV q12h ×1 → 4 mg/kg IV q12h</td><td>6–12 weeks</td><td>Monitor LFTs and levels</td></tr>
</table>

<h3>Cryptococcus spp.</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Amphotericin B + Flucytosine</td><td>AmB 0.7–1 mg/kg IV + Flucytosine 100 mg/kg/day PO</td><td>2 weeks induction → Fluconazole 8–10 weeks</td><td>Monitor renal and CBC</td></tr>
</table>
</div>

<!-- Viral Infections -->
<div id="viruses" style="display:none">
<h2>Viral Infections</h2>

<h3>Influenza A/B</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Oseltamivir</td><td>75 mg PO BID</td><td>5 days</td><td>Start within 48h; adjust renal</td></tr>
</table>

<h3>HSV / VZV</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Acyclovir</td><td>5–10 mg/kg IV q8h</td><td>7–14 days</td><td>Adjust renal; immunocompromised may require longer</td></tr>
</table>

<h3>CMV</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Ganciclovir</td><td>5 mg/kg IV q12h</td><td>14–21 days</td><td>Step-down to oral valganciclovir; monitor CBC & renal</td></tr>
</table>
</div>

<!-- Pathogen-Based Guidance -->
<div id="pathogen" style="display:none">
<h2>Pathogen-Based Guidance</h2>
<p>Includes Gram-stain and culture-directed therapy for Gram-positive, Gram-negative, anaerobic, aerobic, intracellular bacteria, as well as fungal and viral guidance. (Tables and dosing included above in infections sections.)</p>
</div>

<!-- Pathogen Overview -->
<div id="overview" style="display:none">
<h2>Pathogen Overview</h2>

<!-- Include all expandable pathogen summaries as provided previously -->
<!-- Paste the full Pathogen Overview code from my previous message here -->
</div>

<!-- Antibiotic Classes / Escalation -->
<div id="classes" style="display:none">
<h2>Antibiotic Classes / Escalation</h2>
<table>
<tr><th>Class</th><th>Examples</th><th>Notes / Spectrum</th></tr>
<tr><td>Beta-lactams</td><td>Penicillins, Cephalosporins, Carbapenems</td><td>Broad coverage; adjust for renal</td></tr>
<tr><td>Glycopeptides</td><td>Vancomycin, Teicoplanin</td><td>Gram-positive, MRSA coverage</td></tr>
<tr><td>Fluoroquinolones</td><td>Ciprofloxacin, Levofloxacin</td><td>Broad Gram-negative ± Gram-positive; caution in resistance</td></tr>
<tr><td>Macrolides</td><td>Azithromycin, Clarithromycin</td><td>Respiratory pathogens; atypical coverage</td></tr>
<tr><td>Echinocandins</td><td>Micafungin, Caspofungin</td><td>Invasive Candida; IV only</td></tr>
<tr><td>Azoles</td><td>Fluconazole, Voriconazole</td><td>Fungal coverage; check interactions and LFTs</td></tr>
<tr><td>Antivirals</td><td>Oseltamivir, Acyclovir, Ganciclovir</td><td>Specific viral coverage; renal dosing needed</td></tr>
</table>
</div>

<!-- References -->
<div id="references" style="display:none">
<h2>References</h2>
<ul>
<li>IDSA Guidelines 2016–2023</li>
<li>Harrison's Principles of Internal Medicine, 20th Edition</li>
<li>NEJM & JAMA articles on antimicrobial therapy</li>
</ul>
</div>

</div>
</body>
</html>
